nimodipine · Powder

What changed in the last 90 days

Every detected change for nimodipine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Dihydropyridine Calcium Channel Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• aamlodipine and olmesartan medoxomil· 1 maker
• amlodipine besylate and atorvastatin calcium· 1 maker
• amlodipine besylate and valsartan· 1 maker
• amlodipine valsartan and hydrochlorothiazide· 1 maker
• amlodipine,valsartan and hydrochlorothiazide· 1 maker
• clevipidine· 1 maker
• felodipine extended-release tablets· 1 maker
• nicardipine· 1 maker
• olmesartan medoxomil amlodipine and hydrochlorothiazide· 1 maker
• olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide· 1 maker
• olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide· 1 maker
• telmisartan, amlodipine and indapamide· 1 maker

Common questions

Is Nimodipine in shortage right now?

No. FDA does not currently list Nimodipine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Nimodipine?

11 companies have marketed Nimodipine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Nimodipine cost?

The typical pharmacy pays about $1.25 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.